StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
139
This month
3
This week
2
This year
17
Yesterday
1
Publishing Date
2024 - 03 - 26
2
2024 - 02 - 27
2
2023 - 12 - 08
2
2023 - 11 - 01
2
2023 - 08 - 01
3
2023 - 05 - 09
3
2022 - 10 - 12
2
2022 - 09 - 19
1
2022 - 09 - 14
2
2022 - 09 - 07
1
2022 - 09 - 02
1
2022 - 08 - 25
1
2022 - 08 - 18
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 08 - 02
1
2022 - 07 - 27
1
2022 - 07 - 26
1
2022 - 06 - 28
1
2022 - 06 - 20
1
2022 - 06 - 13
1
2022 - 06 - 10
1
2022 - 06 - 06
1
2022 - 05 - 23
1
2022 - 05 - 10
1
2022 - 05 - 04
3
2022 - 05 - 03
1
2022 - 04 - 26
1
2022 - 04 - 25
1
2022 - 04 - 18
1
2022 - 04 - 12
1
2022 - 04 - 11
1
2022 - 04 - 04
1
2022 - 03 - 09
1
2022 - 03 - 01
2
2022 - 02 - 24
1
2022 - 02 - 22
3
2022 - 02 - 18
1
2022 - 02 - 17
1
2022 - 02 - 15
1
2022 - 02 - 10
1
2022 - 02 - 04
1
2022 - 02 - 01
1
2022 - 01 - 18
1
2022 - 01 - 07
1
2022 - 01 - 04
1
2021 - 12 - 13
2
2021 - 12 - 10
1
2021 - 12 - 07
1
2021 - 12 - 02
1
2021 - 11 - 25
1
2021 - 11 - 18
1
2021 - 11 - 03
1
2021 - 08 - 04
1
2021 - 07 - 29
1
2021 - 07 - 06
1
2021 - 05 - 11
1
2021 - 05 - 05
1
2021 - 01 - 22
1
2020 - 12 - 15
1
Sector
Distribution services
1
Electronic technology
1
Finance
3
Finance and insurance
1
Health services
1
Health technology
139
Manufacturing
9
N/a
2
Process industries
1
Professional, scientific, and technical services
8
Tags
Agreement
25
Alliances
39
Alzheimer's
23
Alzheimer’s
23
Antibody
51
Approval
46
Biomidwest
40
Biopharma
36
Biotech-bay
24
Biotechnology
25
Cancer
139
China
47
Chinese
28
Clinical-trials-phase-iii
32
Collaboration
71
Companies
51
Conference
76
Covid
62
Covid-19
48
Designation
22
Diabetes
57
Disease
89
Drug
105
Earnings
45
Events
32
Expected
24
Fda
71
Financial
65
Financial results
42
Global
149
Growth
108
Health
30
Heart
23
Insulin
37
Iot
23
License
26
Market
306
Meeting
26
Money
34
N/a
1120
Obesity
28
People
70
Pharma
35
Pharmaceutical
24
Phase 1
24
Phase 2
34
Phase 3
47
Positive
30
Report
141
Research
148
Results
203
Risk
24
Study
74
Technology
27
Therapeutics
139
Therapy
88
Tirzepatide
24
Treatment
175
Trial
116
Update
33
Entities
Abbvie inc.
88
Abeona therapeutics inc.
73
Adc therapeutics sa
82
Agile therapeutics, inc.
61
Akebia therapeutics, inc.
67
Akero therapeutics, inc.
63
Aldeyra therapeutics, inc.
58
Aligos therapeutics, inc.
57
Allogene therapeutics, inc.
86
Altamira therapeutics ltd
55
Alterity therapeutics limited
74
Amgen inc.
69
Amicus therapeutics, inc.
56
Amplitude healthcare acquisition corp
59
Aquestive therapeutics, inc.
82
Astrazeneca plc
70
Axsome therapeutics, inc.
79
Bioxcel therapeutics, inc.
62
Brainstorm cell therapeutics inc.
57
Cidara therapeutics, inc.
61
Cognition therapeutics inc
79
Crispr therapeutics ag
61
Cytomx therapeutics, inc.
64
Eli lilly and company
139
Fortress biotech, inc.
73
Fulcrum therapeutics, inc.
74
G1 therapeutics, inc.
81
Glaxosmithkline plc
83
Horizon therapeutics public limited company
74
Hoth therapeutics, inc.
68
Inhibikase therapeutics, inc.
66
Intellia therapeutics, inc.
56
Johnson & johnson
186
Kymera therapeutics, inc.
64
Morgan stanley
148
Novartis ag
114
Nurix therapeutics, inc.
61
Omega therapeutics inc
55
Oncternal therapeutics, inc.
57
Orange
66
Outlook therapeutics, inc.
71
Pliant therapeutics, inc.
70
Plus therapeutics, inc.
84
Poseida therapeutics, inc.
60
Ptc therapeutics, inc.
57
Relief therapeutics holding sa
80
Sanofi
342
Sarepta therapeutics, inc.
72
Seres therapeutics, inc.
62
Spero therapeutics, inc.
70
Springworks therapeutics, inc.
58
Teva pharmaceutical industries ltd
64
Tg therapeutics, inc.
88
Transcode therapeutics inc
68
Travere therapeutics inc.
79
Trevi therapeutics, inc.
55
Tscan therapeutics inc
65
Vera therapeutics inc - class a
55
Vivos therapeutics inc
56
Voyager therapeutics, inc.
74
Symbols
ABBV
8
ABT
3
ACRS
6
ACRV
1
AKTX
2
AKYA
1
ALDX
1
ALKS
2
ALLR
1
ALPMF
5
ALPMY
5
AMGN
4
ANNX
1
ASMB
1
ATXI
2
AUTL
1
AXSM
1
AZN
11
AZNCF
11
BDTX
1
BEAM
1
BHC
1
BIIB
3
BMO
1
BMY
5
BNPQF
1
BNPQY
1
BNTX
1
BYSI
1
CALA
1
CBAY
1
DICE
2
FBIO
2
GLAXF
12
GSK
12
INCY
5
JNJ
15
KDNY
3
LLY
139
MNKD
2
NKTR
4
NVO
4
NVS
10
NVSEF
10
PFE
4
PRQR
3
REGN
2
RIGL
2
SGTX
3
SNY
16
SNYNF
16
TAK
6
TEVA
3
TEVJF
5
TMO
2
UCBJF
2
UCBJY
2
UTHR
12
VERV
5
VRTX
2
Exchanges
Nasdaq
94
Nyse
139
Crawled Date
2024 - 03 - 26
2
2024 - 02 - 27
2
2023 - 12 - 08
2
2023 - 11 - 01
2
2023 - 08 - 01
3
2023 - 05 - 09
3
2022 - 10 - 12
2
2022 - 09 - 19
1
2022 - 09 - 14
2
2022 - 09 - 07
1
2022 - 09 - 02
1
2022 - 08 - 25
1
2022 - 08 - 18
1
2022 - 08 - 05
1
2022 - 08 - 03
1
2022 - 08 - 02
1
2022 - 07 - 27
1
2022 - 07 - 26
1
2022 - 07 - 06
1
2022 - 06 - 28
1
2022 - 06 - 20
1
2022 - 06 - 13
1
2022 - 06 - 10
1
2022 - 06 - 06
1
2022 - 05 - 23
1
2022 - 05 - 04
3
2022 - 05 - 03
1
2022 - 04 - 26
1
2022 - 04 - 25
1
2022 - 04 - 18
1
2022 - 04 - 12
1
2022 - 04 - 11
1
2022 - 04 - 04
1
2022 - 03 - 09
1
2022 - 03 - 01
2
2022 - 02 - 24
1
2022 - 02 - 22
3
2022 - 02 - 18
1
2022 - 02 - 17
1
2022 - 02 - 15
1
2022 - 02 - 10
1
2022 - 02 - 05
1
2022 - 02 - 02
1
2022 - 01 - 18
1
2022 - 01 - 07
1
2022 - 01 - 04
1
2021 - 12 - 13
2
2021 - 12 - 10
1
2021 - 12 - 07
1
2021 - 12 - 02
1
2021 - 11 - 25
1
2021 - 11 - 18
1
2021 - 11 - 03
1
2021 - 08 - 04
1
2021 - 07 - 29
1
2021 - 07 - 06
1
2021 - 05 - 11
1
2021 - 05 - 05
1
2021 - 01 - 22
1
2020 - 12 - 15
1
Crawled Time
00:00
1
00:20
1
01:00
2
02:00
4
03:00
1
04:00
1
04:20
1
06:00
2
08:00
1
10:00
1
11:00
17
12:00
23
12:11
1
12:20
5
12:30
5
13:00
14
13:20
5
13:30
1
14:00
4
14:07
1
14:20
2
14:30
3
15:00
10
15:20
4
15:30
1
16:00
4
17:00
3
18:00
3
19:00
1
20:00
6
21:00
4
22:00
2
23:00
5
Source
www.biospace.com
65
www.globenewswire.com
29
www.prnewswire.com
45
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Therapeutics
entities :
Eli lilly and company
save search
Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published:
2024-04-19
(Crawled : 15:00)
- prnewswire.com
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
0.66%
|
O:
0.24%
H:
0.42%
C:
0.42%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-1.46%
|
O:
-0.84%
H:
0.86%
C:
-0.62%
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
0.38%
|
O:
-0.58%
H:
0.99%
C:
0.97%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.26%
|
O:
-0.21%
H:
0.11%
C:
-3.05%
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
0.42%
|
O:
-0.18%
H:
0.84%
C:
0.6%
report
reach
therapeutics
market
CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
Published:
2024-04-15
(Crawled : 20:00)
- globenewswire.com
CRGX
|
$19.16
0.31%
0.31%
200K
|
|
-3.52%
|
O:
-1.76%
H:
6.0%
C:
2.35%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.26%
|
O:
0.09%
H:
0.0%
C:
0.0%
BDTX
|
$5.26
-0.76%
-0.76%
390K
|
Health Technology
|
0.77%
|
O:
0.57%
H:
2.86%
C:
2.48%
AUTL
|
$4.51
-6.04%
-6.43%
1.4M
|
Health Technology
|
-7.76%
|
O:
0.0%
H:
2.04%
C:
-0.82%
therapeutics
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
Published:
2024-04-09
(Crawled : 20:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-4.08%
|
O:
-0.71%
H:
0.0%
C:
0.0%
ORIC
|
$9.2
-3.26%
-3.37%
670K
|
Health Technology
|
-13.87%
|
O:
-2.81%
H:
1.54%
C:
-3.57%
NRIX
3 d
|
$13.6
-5.82%
-6.18%
1M
|
Health Technology
|
-3.51%
|
O:
18.35%
H:
1.98%
C:
-5.88%
therapeutics
Bicara Therapeutics Expands Clinical Team with Appointments of Jeltje Schulten, M.D., MBA, as SVP of Clinical and Medical Affairs and Rita Dalal, MBBS, MPH, as VP of Clinical Development
Published:
2024-03-26
(Crawled : 20:00)
- biospace.com/
MURA
|
$3.55
-0.56%
-0.56%
240K
|
|
-17.36%
|
O:
3.7%
H:
2.57%
C:
0.22%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.06%
|
O:
0.14%
H:
0.53%
C:
0.09%
medical
therapeutics
Laverock Therapeutics announces appointment of Ali Elsley as Finance Director and expansion of team
Published:
2024-03-26
(Crawled : 11:00)
- biospace.com/
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.06%
|
O:
0.14%
H:
0.53%
C:
0.09%
expansion
therapeutics
Capstan Therapeutics Announces $175M Oversubscribed Series B Financing
Published:
2024-03-20
(Crawled : 13:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.55%
|
O:
-0.65%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-6.01%
|
O:
-0.35%
H:
0.4%
C:
0.36%
series
therapeutics
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Published:
2024-03-15
(Crawled : 14:30)
- prnewswire.com
TAK
|
News
|
$13.24
0.61%
0.0%
1.3M
|
Health Technology
|
-7.67%
|
O:
0.21%
H:
0.97%
C:
0.7%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.84%
|
O:
0.05%
H:
0.14%
C:
-0.93%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.01%
|
O:
-1.58%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-4.52%
|
O:
-0.7%
H:
0.73%
C:
-0.16%
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
-7.71%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.4%
|
O:
-0.02%
H:
0.0%
C:
0.0%
REGN
|
$896.27
0.26%
0.25%
500K
|
Health Technology
|
-6.49%
|
O:
-0.27%
H:
1.26%
C:
0.84%
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
-0.96%
|
O:
0.2%
H:
1.14%
C:
-1.18%
antibody
therapeutics
market
MOMA Therapeutics Appoints Jullian G. Jones, Ph.D., J.D., MBA, as Chief Business Officer
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-4.7%
|
O:
-1.3%
H:
0.61%
C:
-2.37%
business
therapeutics
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-27
(Crawled : 12:30)
- globenewswire.com
VERV
|
News
|
$6.64
-0.3%
-0.3%
1.1M
|
Professional, Scientific, and T...
|
-54.02%
|
O:
5.89%
H:
15.96%
C:
14.72%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-5.91%
|
O:
-2.2%
H:
2.39%
C:
1.34%
VRTX
|
News
|
$394.43
0.24%
0.24%
1.3M
|
Health Technology
|
-9.04%
|
O:
0.15%
H:
0.66%
C:
-0.74%
year
pipeline
therapeutics
financial
results
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Published:
2024-02-27
(Crawled : 12:00)
- globenewswire.com
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-5.91%
|
O:
-2.2%
H:
2.39%
C:
1.34%
ACRS
|
$1.25
1.63%
1.6%
580K
|
Health Technology
|
2.48%
|
O:
2.48%
H:
10.48%
C:
-3.23%
year
update
therapeutics
financial
results
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-02-21
(Crawled : 12:00)
- biospace.com/
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.88%
|
O:
-2.33%
H:
1.55%
C:
1.06%
UTHR
|
$237.99
0.45%
0.45%
400K
|
Health Technology
|
11.1%
|
O:
2.59%
H:
3.66%
C:
-0.24%
year
corporation
therapeutics
financial
results
Animal Therapeutics and Diagnostics Global Market Report 2024 - Dermatological Disease Management in Animals to Propel Market Growth
Published:
2024-02-13
(Crawled : 23:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-2.71%
H:
0.0%
C:
0.0%
ZTS
|
News
|
$146.5
-4.32%
0.0%
6.2M
|
Health Technology
|
-20.16%
|
O:
0.93%
H:
0.7%
C:
-0.6%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
1.15%
|
O:
0.56%
H:
1.3%
C:
1.22%
QGEN
|
$40.0
1.34%
0.0%
1.1M
|
Health Technology
|
-6.67%
|
O:
-1.14%
H:
1.3%
C:
1.2%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-2.24%
|
O:
0.38%
H:
2.44%
C:
1.54%
ELAN
|
$12.95
-4.57%
0.0%
5.7M
|
Process Industries
|
-17.46%
|
O:
1.53%
H:
1.16%
C:
0.82%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
0.28%
|
O:
-1.1%
H:
0.0%
C:
0.0%
QGEN
|
$40.0
1.34%
0.0%
1.1M
|
Health Technology
|
-6.67%
|
O:
-1.14%
H:
1.3%
C:
1.2%
PAHC
|
$13.31
2.07%
2.03%
130K
|
Health Technology
|
17.39%
|
O:
1.32%
H:
4.7%
C:
4.09%
NEOG
P
|
$11.6
-2.77%
-2.84%
1.9M
|
Health Technology
|
-29.38%
|
O:
-0.24%
H:
4.39%
C:
3.29%
management
propel
disease
report
animal
global
animals
dermatological
diagnostics
therapeutics
growth
market
Global IV & Oral Iron Drugs Market Report 2024: Market to Reach $16.43 Billion by 2029 with CSL Vifor, Covis Pharmaceuticals, Daiichi Sankyo, Akebia Therapeutics, Shield Therapeutics Dominating
Published:
2024-02-10
(Crawled : 04:20)
- prnewswire.com
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
report
reach
global
therapeutics
market
Arkuda Therapeutics Announces Option and Asset Purchase Agreement
Published:
2024-02-07
(Crawled : 15:00)
- biospace.com/
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.03%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
3.02%
|
O:
0.76%
H:
4.31%
C:
2.11%
therapeutics
agreement
Gallant Therapeutics Adds Animal Health Executive Aaron Schacht to Board of Directors
Published:
2024-02-06
(Crawled : 15:00)
- biospace.com/
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
2.85%
|
O:
5.07%
H:
0.0%
C:
-4.98%
health
animal
therapeutics
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published:
2024-01-10
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-10.95%
|
O:
1.1%
H:
0.0%
C:
0.0%
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
12.92%
|
O:
-0.33%
H:
0.35%
C:
-1.5%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
15.25%
|
O:
0.67%
H:
0.85%
C:
0.21%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-10.93%
|
O:
0.69%
H:
0.0%
C:
0.0%
ALDX
|
$3.865
-2.89%
-2.98%
430K
|
Health Technology
|
15.57%
|
O:
-1.8%
H:
0.46%
C:
-2.44%
companies
therapeutics
growth
market
Nimbus Therapeutics Announces Expansion of Its Immunology Drug Discovery Pipeline
Published:
2024-01-05
(Crawled : 14:00)
- biospace.com/
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
18.2%
|
O:
-0.08%
H:
0.97%
C:
0.74%
drug
pipeline
expansion
immunology
therapeutics
Global Branded PAH Therapeutics Market Report 2023-2029 - Targeted Therapies Revolutionize Treatment, Growing Prevalence Spurs Market Expansion for Branded Therapeutics
Published:
2023-12-15
(Crawled : 02:00)
- prnewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-5.51%
|
O:
-0.39%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
22.34%
|
O:
-4.44%
H:
0.0%
C:
0.0%
report
expansion
global
growing
therapeutics
market
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
Published:
2023-12-14
(Crawled : 12:00)
- globenewswire.com
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-3.8%
|
O:
1.81%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
24.54%
|
O:
1.8%
H:
0.0%
C:
0.0%
BEAM
|
$23.9
-1.69%
-1.72%
4.5M
|
Health Technology
|
-15.49%
|
O:
3.61%
H:
3.21%
C:
1.67%
biotech
therapeutics
Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R. Graff, PhD as Key Executive Advisor
Published:
2023-12-12
(Crawled : 11:00)
- globenewswire.com
ALLR
|
$1.42
-7.79%
-8.45%
460K
|
n/a
|
186.01%
|
O:
-2.26%
H:
9.41%
C:
7.03%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
21.33%
|
O:
-2.88%
H:
0.0%
C:
0.0%
ceo
therapeutics
← Previous
1
2
3
4
5
6
7
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
GBR
|
$1.42
31.48%
11.27%
990K
|
Energy Minerals
KUKE
|
$2.88
2.49%
7.64%
360K
|
MPLN
|
$0.6502
-11.74%
4.51%
2.2M
|
Finance
CXM
4
|
$11.34
-0.44%
4.27%
1.7M
|
Information
PVL
4
|
$1.47
-0.68%
4.08%
77K
|
Energy Minerals
RNR
4
|
$224.74
0.85%
3.52%
310K
|
Finance
PZG
|
$0.4431
0.48%
2.91%
150K
|
Non-Energy Minerals
LEV
|
$0.972
0.73%
2.88%
570K
|
Manufacturing
AJX
4
|
$3.47
2.06%
2.02%
110K
|
Finance
DBRG
|
$17.3
0.06%
1.97%
1.2M
|
Finance and Insurance
Your saved searches
Save your searches and get alerts when important news are released.